Published by Todd Bush on August 22, 2023
August 22, 2023 09:13 AM Eastern Daylight Time
DENVER--(BUSINESS WIRE)--Cascade Biocatalysts, a biomanufacturing company catalyzing green chemistry, raised an oversubscribed $2.6 M pre-seed led by Ten VC with participation from mplify.LA, Boost VC, Range Ventures, Spacecadet, and the Cool Climate Collective. Cascade aims to use the raised funds to scale its impact from the lab bench to pilot scale and to support its initial wave of customers.
Cascade's co-founders: Alex Rosay (CEO, left) and James Weltz (CSO, right)
Cascade’s vision is to make the industrial use of enzymes more affordable to accelerate the transition to greener chemical manufacturing. At the heart of Cascade Biocatalysts' breakthrough lies its proprietary technology, the patent-pending Body Armor for Enzymes™, which drives more cost-effective and sustainable chemical reactions by improving enzyme performance.
The inventor and his creation: James Weltz, Cascade's CSO, with his novel enzyme immobilization solution
For billions of years, nature has relied on enzymes to efficiently make useful molecules. Cascade is moving nature's catalysts out of the cell and into the factory, transitioning chemical manufacturing away from energy-intensive, petrochemical-based processes. By doing so, the company aims to address the three gigatons of greenhouse gas emissions generated by the chemicals industry. Overcoming the current barrier of enzyme cost is a crucial step toward making this a reality.
Cascade’s technology uses readily available and cost-effective materials to keep expensive enzymes lasting significantly longer. So far, Cascade has worked on 15 different enzymes and is 100% successful at improving stability under tough industrial conditions, including for multiple paying customers at the lab scale. Find more data in this article that highlights Cascade’s potential in creating molecular factories. The company's initial projects span diverse applications, including carbon dioxide capture, fragrance manufacturing, and wastewater treatment, highlighting the broad commercial potential of biocatalysts.
The company's co-founders, Alex Rosay and James Weltz, bring together chemical engineering backgrounds, industry expertise, and scientific innovation.
James invented the technology while doing his PhD in the field of enzyme immobilization. “I had tried all other solutions, and they were inconsistent,” said James Weltz, Cascade’s Chief Scientific Officer (CSO). “When I developed our novel approach, I transformed immobilizing enzymes from a trial-and-error process into an engineering discipline.”
“From the moment I met James, I knew his technology would revolutionize biomanufacturing,” said Alex Rosay, CEO and industry veteran. “From my time as a product manager at Zymergen, I saw a billion dollars go towards precision fermentation unsuccessfully, and I realized cell-free and enzyme processes were the future of the industry, though too expensive today. James’s technology solves this.”
With its headquarters in Denver and a presence in California and New York, Cascade Biocatalysts is well-positioned to spearhead the cell-free biomanufacturing revolution. Interested parties can contact Alex Rosay at [email protected] to learn more.
>> In Other News: Astronergy, NIO and OPF hand for the world's first EV PV Self-consumption System with V2G Chargers at Qilian Mountain National Park
Cascade Biocatalysts specializes in advancing enzyme-based processes. With its groundbreaking Body Armor for Enzymes™ technology, the company seeks to drive greener and more cost-effective chemical reactions, reducing greenhouse gas emissions and promoting sustainability across industries. Headquartered in Denver, Cascade is committed to scaling up its impact and revolutionizing the future of the chemical economy.
Follow the money flow of climate, technology, and energy investments to uncover new opportunities and jobs.
Inside This Issue ⚡ Energy Department Removes Barriers for American Energy Producers, Unleashing Investment in Domestic Hydrogen 🛳️ MASH Makes Powers First Vessel Trial With Biofuel From a Carbon-...
Inside This Issue 🛢️ Conestoga Energy Completes Drilling of Class VI Carbon Capture & Sequestration Well, Advances Toward EPA Application 🏗️ How Microsoft and Sublime Systems Are Reinventing C...
Inside This Issue 💸 EDF Slams Repeal of 45V Hydrogen Credit, Citing $32Bn in Higher Household Energy Costs and Job Losses 🤝 Johnson Matthey to Sell Blue Hydrogen Business to Honeywell as Part of £...
The U.S. Department of Energy’s (DOE) Hydrogen and Fuel Cell Technologies Office today removed barriers for the American hydrogen industry by updating its 45VH2-GREET modeling tool. The latest vers...
NETL Patents New Process for Extracting Critical Resources from Coal Fly Ash at High Quantities
NETL researchers developed a new process for extracting economically and strategically vital rare earth elements (REE) and critical minerals (CM) from America’s coal fly ash at high quantities and ...
World’s First Plant That Captures CO2 From Air to Make Building Materials Opens
Aggregates produced using CO2 captured by Mission Zero Technologies ‘Direct Air Capture’ technology (Image courtesy of Mission Zero Technologies) A demonstration project that uses direct air captu...
Plug Power’s Georgia Hydrogen Plant Sets U.S. Production Record Using Plug Electrolyzer Technology
April 2025 Marks Industry-Leading Milestone with 300 Metric Tons of Liquid Hydrogen Produced WOODBINE, Ga., -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, ...
Follow the money flow of climate, technology, and energy investments to uncover new opportunities and jobs.